The completion of enrollment in the DuraSorb Monofilament Mesh U.S. IDE study is a significant milestone for Integra LifeSciences. It indicates that the company is making progress in its research and development efforts, which could potentially lead to the introduction of new products and services in the future. This could have a positive impact on the company's stock price in the short term.